Wikipedia -WSS

Wikipedia

author：explore 2025-09-29 01:38:50 - browse：34

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Biogen says it will cut costs by $700 million, slash 1,000 jobs

Wikipedia

WSS

FDA's Pazdur wants cancer trials to range beyond China alone

Dems pitch expanding Medicare power to negotiate drug prices

Ionis drug prevents swelling attacks due to hereditary angioedema

Let's speed up science by embracing open access publishing

Intellia reports positive results for its CRISPR

New lawsuit accuses health insurer Cigna of denying claims in bulk

hotspot

Wikipedia

hotspot

Moonlake's readout produced a cash windfall. Risks remain

BMI, flaws aside, is found to be useful estimate of body fat in youth

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How doctors’ personal politics affect patients

Anesthesiologist group: stop taking Ozempic before surgery

At ASCO, AstraZeneca reports strong data for breast cancer drug

Cancer drug shortages should be causing more outrage

Woman returns to dialysis after doctors remove transplanted pig kidney

Cancer drug shortages should be causing more outrage

A new crop of companies is reshaping the health data economy

explore

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Why patients can’t get everything they want on drug pricing

In the gardens at Boston Children's Hospital, families find sanctuary

The haunting brain science of long Covid

NIH documents show early flaws of $1.6 billion long Covid program

Device maker Teleflex to acquire urology company for $600M

hotspot

explore

Wikipedia

explore